HEADER TRANSFERASE 29-SEP-21 7PUE TITLE HUMAN SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH TITLE 2 PYRAZOLOPYRIDINE INHIBITOR 3A COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE SGK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERUM/GLUCOCORTICOID-REGULATED KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SGK1, SGK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS SERINE/THREONINE PROTEIN KINASE, ATP-COMPETITIVE INHIBITOR, DFG-LOOP, KEYWDS 2 HINGE-BINDER, OSTEOARTHRITIS, CARTILAGE DEGRADATION, PYRAZOLO- KEYWDS 3 PYRIDINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.K.DREYER,N.HALLAND,M.NAZARE REVDAT 4 01-MAY-24 7PUE 1 REMARK REVDAT 3 09-FEB-22 7PUE 1 JRNL REVDAT 2 02-FEB-22 7PUE 1 JRNL REVDAT 1 01-DEC-21 7PUE 0 JRNL AUTH N.HALLAND,F.SCHMIDT,T.WEISS,Z.LI,J.CZECH,J.SAAS, JRNL AUTH 2 D.DING-PFENNIGDORFF,M.K.DREYER,C.STRUBING,M.NAZARE JRNL TITL RATIONAL DESIGN OF HIGHLY POTENT, SELECTIVE, AND JRNL TITL 2 BIOAVAILABLE SGK1 PROTEIN KINASE INHIBITORS FOR THE JRNL TITL 3 TREATMENT OF OSTEOARTHRITIS. JRNL REF J.MED.CHEM. V. 65 1567 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 34931844 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01601 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 70.1 REMARK 3 NUMBER OF REFLECTIONS : 10904 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 767 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.71 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 9.19 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3109 REMARK 3 BIN FREE R VALUE : 0.3479 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 23 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2155 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 24 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.75210 REMARK 3 B22 (A**2) : 3.75210 REMARK 3 B33 (A**2) : -7.50410 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.370 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.686 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.316 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.634 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.316 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2263 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3074 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 741 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 371 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2263 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 281 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1760 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.26 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 11.59 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -26.636 26.2033 1.454 REMARK 3 T TENSOR REMARK 3 T11: -0.0887 T22: -0.3699 REMARK 3 T33: -0.3826 T12: 0.0509 REMARK 3 T13: 0.0326 T23: 0.0637 REMARK 3 L TENSOR REMARK 3 L11: 3.2019 L22: 3.8399 REMARK 3 L33: 5.1137 L12: -0.5842 REMARK 3 L13: 0.9468 L23: -0.6138 REMARK 3 S TENSOR REMARK 3 S11: 0.0681 S12: -0.18 S13: -0.9301 REMARK 3 S21: -0.18 S22: 0.036 S23: -0.1308 REMARK 3 S31: -0.9301 S32: -0.1308 S33: -0.1041 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7PUE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1292118102. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10904 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 19.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : 8.500 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.3 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.38800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: EARLIER IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 25 MM HEPES, 100 MM REMARK 280 NACL,1 MM DTT, 5 MM MGCL2 PH 7.8; 3 MM AMPPNP; RESERVOIR REMARK 280 SOLUTION: 12% PEG3350, 200 MM NAF; SOAKING IN RES.SOL.+ 10 MM REMARK 280 CPD3A, 10% DMSO, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 114.68867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 57.34433 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 86.01650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 28.67217 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 143.36083 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 114.68867 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 57.34433 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 28.67217 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 86.01650 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 143.36083 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 57 REMARK 465 ALA A 58 REMARK 465 MET A 59 REMARK 465 ILE A 60 REMARK 465 SER A 61 REMARK 465 GLN A 62 REMARK 465 PRO A 63 REMARK 465 GLN A 64 REMARK 465 GLU A 65 REMARK 465 PRO A 66 REMARK 465 GLU A 67 REMARK 465 LEU A 68 REMARK 465 MET A 69 REMARK 465 ASN A 70 REMARK 465 ALA A 71 REMARK 465 ASN A 72 REMARK 465 PRO A 73 REMARK 465 SER A 74 REMARK 465 PRO A 75 REMARK 465 PRO A 76 REMARK 465 PRO A 77 REMARK 465 SER A 78 REMARK 465 PRO A 79 REMARK 465 SER A 80 REMARK 465 GLN A 81 REMARK 465 SER A 108 REMARK 465 PHE A 109 REMARK 465 LEU A 135 REMARK 465 LYS A 136 REMARK 465 LYS A 137 REMARK 465 LYS A 138 REMARK 465 GLU A 139 REMARK 465 GLU A 140 REMARK 465 LYS A 141 REMARK 465 HIS A 142 REMARK 465 ILE A 143 REMARK 465 MET A 144 REMARK 465 SER A 145 REMARK 465 GLU A 146 REMARK 465 ARG A 147 REMARK 465 ASN A 148 REMARK 465 GLU A 246 REMARK 465 ASN A 247 REMARK 465 ILE A 248 REMARK 465 GLU A 249 REMARK 465 HIS A 250 REMARK 465 ASN A 251 REMARK 465 SER A 252 REMARK 465 THR A 253 REMARK 465 SER A 377 REMARK 465 GLY A 378 REMARK 465 PRO A 379 REMARK 465 ASN A 380 REMARK 465 ASP A 381 REMARK 465 LEU A 382 REMARK 465 ARG A 383 REMARK 465 HIS A 384 REMARK 465 PHE A 385 REMARK 465 ASP A 386 REMARK 465 PRO A 387 REMARK 465 GLU A 388 REMARK 465 PHE A 389 REMARK 465 THR A 390 REMARK 465 GLU A 391 REMARK 465 GLU A 392 REMARK 465 PRO A 393 REMARK 465 VAL A 394 REMARK 465 PRO A 395 REMARK 465 ASN A 396 REMARK 465 SER A 397 REMARK 465 ILE A 398 REMARK 465 GLY A 399 REMARK 465 LYS A 400 REMARK 465 SER A 401 REMARK 465 PRO A 402 REMARK 465 ASP A 403 REMARK 465 SER A 404 REMARK 465 VAL A 405 REMARK 465 LEU A 406 REMARK 465 VAL A 407 REMARK 465 THR A 408 REMARK 465 ALA A 409 REMARK 465 SER A 410 REMARK 465 VAL A 411 REMARK 465 LYS A 412 REMARK 465 GLU A 413 REMARK 465 ALA A 414 REMARK 465 ALA A 415 REMARK 465 GLU A 416 REMARK 465 ALA A 417 REMARK 465 PHE A 418 REMARK 465 LEU A 419 REMARK 465 GLY A 420 REMARK 465 PHE A 421 REMARK 465 ASP A 422 REMARK 465 TYR A 423 REMARK 465 ALA A 424 REMARK 465 PRO A 425 REMARK 465 PRO A 426 REMARK 465 THR A 427 REMARK 465 ASP A 428 REMARK 465 SER A 429 REMARK 465 PHE A 430 REMARK 465 LEU A 431 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 94 CG CD CE NZ REMARK 470 LYS A 106 CG CD CE NZ REMARK 470 GLU A 120 CG CD OE1 OE2 REMARK 470 GLU A 121 CG CD OE1 OE2 REMARK 470 LYS A 131 CG CD CE NZ REMARK 470 LYS A 132 CG CD CE NZ REMARK 470 VAL A 149 CG1 CG2 REMARK 470 LEU A 150 CG CD1 CD2 REMARK 470 GLN A 233 CG CD OE1 NE2 REMARK 470 LYS A 245 CG CD CE NZ REMARK 470 LYS A 343 CG CD CE NZ REMARK 470 ASN A 375 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 85 13.29 59.05 REMARK 500 LEU A 101 -74.56 -66.89 REMARK 500 LYS A 118 43.74 -90.04 REMARK 500 ALA A 119 125.71 -171.33 REMARK 500 GLU A 121 48.11 24.31 REMARK 500 LEU A 129 -63.86 -105.25 REMARK 500 GLN A 130 111.66 108.62 REMARK 500 LYS A 131 -55.41 -29.59 REMARK 500 LYS A 132 83.70 -66.15 REMARK 500 ALA A 133 34.97 -159.59 REMARK 500 LEU A 151 -128.68 48.38 REMARK 500 LYS A 152 8.43 56.62 REMARK 500 ALA A 169 29.55 140.14 REMARK 500 ASP A 170 -33.03 -177.92 REMARK 500 ALA A 192 -47.92 70.64 REMARK 500 ARG A 221 -47.28 67.78 REMARK 500 ASP A 222 43.04 -104.20 REMARK 500 PHE A 241 38.15 -96.18 REMARK 500 CYS A 258 -99.42 61.89 REMARK 500 HIS A 270 40.55 -99.97 REMARK 500 LYS A 271 66.45 36.14 REMARK 500 ASP A 275 -153.08 -140.72 REMARK 500 LEU A 332 41.47 -95.94 REMARK 500 ASP A 345 -132.14 45.54 REMARK 500 REMARK 500 REMARK: NULL DBREF 7PUE A 60 431 UNP O00141 SGK1_HUMAN 60 431 SEQADV 7PUE GLY A 57 UNP O00141 EXPRESSION TAG SEQADV 7PUE ALA A 58 UNP O00141 EXPRESSION TAG SEQADV 7PUE MET A 59 UNP O00141 EXPRESSION TAG SEQADV 7PUE ALA A 192 UNP O00141 ARG 192 ENGINEERED MUTATION SEQADV 7PUE ASP A 422 UNP O00141 SER 422 ENGINEERED MUTATION SEQRES 1 A 375 GLY ALA MET ILE SER GLN PRO GLN GLU PRO GLU LEU MET SEQRES 2 A 375 ASN ALA ASN PRO SER PRO PRO PRO SER PRO SER GLN GLN SEQRES 3 A 375 ILE ASN LEU GLY PRO SER SER ASN PRO HIS ALA LYS PRO SEQRES 4 A 375 SER ASP PHE HIS PHE LEU LYS VAL ILE GLY LYS GLY SER SEQRES 5 A 375 PHE GLY LYS VAL LEU LEU ALA ARG HIS LYS ALA GLU GLU SEQRES 6 A 375 VAL PHE TYR ALA VAL LYS VAL LEU GLN LYS LYS ALA ILE SEQRES 7 A 375 LEU LYS LYS LYS GLU GLU LYS HIS ILE MET SER GLU ARG SEQRES 8 A 375 ASN VAL LEU LEU LYS ASN VAL LYS HIS PRO PHE LEU VAL SEQRES 9 A 375 GLY LEU HIS PHE SER PHE GLN THR ALA ASP LYS LEU TYR SEQRES 10 A 375 PHE VAL LEU ASP TYR ILE ASN GLY GLY GLU LEU PHE TYR SEQRES 11 A 375 HIS LEU GLN ARG GLU ALA CYS PHE LEU GLU PRO ARG ALA SEQRES 12 A 375 ARG PHE TYR ALA ALA GLU ILE ALA SER ALA LEU GLY TYR SEQRES 13 A 375 LEU HIS SER LEU ASN ILE VAL TYR ARG ASP LEU LYS PRO SEQRES 14 A 375 GLU ASN ILE LEU LEU ASP SER GLN GLY HIS ILE VAL LEU SEQRES 15 A 375 THR ASP PHE GLY LEU CYS LYS GLU ASN ILE GLU HIS ASN SEQRES 16 A 375 SER THR THR SER THR PHE CYS GLY THR PRO GLU TYR LEU SEQRES 17 A 375 ALA PRO GLU VAL LEU HIS LYS GLN PRO TYR ASP ARG THR SEQRES 18 A 375 VAL ASP TRP TRP CYS LEU GLY ALA VAL LEU TYR GLU MET SEQRES 19 A 375 LEU TYR GLY LEU PRO PRO PHE TYR SER ARG ASN THR ALA SEQRES 20 A 375 GLU MET TYR ASP ASN ILE LEU ASN LYS PRO LEU GLN LEU SEQRES 21 A 375 LYS PRO ASN ILE THR ASN SER ALA ARG HIS LEU LEU GLU SEQRES 22 A 375 GLY LEU LEU GLN LYS ASP ARG THR LYS ARG LEU GLY ALA SEQRES 23 A 375 LYS ASP ASP PHE MET GLU ILE LYS SER HIS VAL PHE PHE SEQRES 24 A 375 SER LEU ILE ASN TRP ASP ASP LEU ILE ASN LYS LYS ILE SEQRES 25 A 375 THR PRO PRO PHE ASN PRO ASN VAL SER GLY PRO ASN ASP SEQRES 26 A 375 LEU ARG HIS PHE ASP PRO GLU PHE THR GLU GLU PRO VAL SEQRES 27 A 375 PRO ASN SER ILE GLY LYS SER PRO ASP SER VAL LEU VAL SEQRES 28 A 375 THR ALA SER VAL LYS GLU ALA ALA GLU ALA PHE LEU GLY SEQRES 29 A 375 PHE ASP TYR ALA PRO PRO THR ASP SER PHE LEU HET GOL A 501 6 HET GOL A 502 6 HET 86H A 503 35 HETNAM GOL GLYCEROL HETNAM 86H 6-[4-[[2,3-BIS(CHLORANYL)PHENYL]SULFONYLAMINO]PHENYL]- HETNAM 2 86H ~{N}-[(3~{R})-PYRROLIDIN-3-YL]-2~{H}-PYRAZOLO[3,4- HETNAM 3 86H B]PYRIDINE-4-CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL 2(C3 H8 O3) FORMUL 4 86H C23 H20 CL2 N6 O3 S FORMUL 5 HOH *24(H2 O) HELIX 1 AA1 LYS A 94 SER A 96 5 3 HELIX 2 AA2 GLU A 183 ALA A 192 1 10 HELIX 3 AA3 LEU A 195 LEU A 216 1 22 HELIX 4 AA4 LYS A 224 GLU A 226 5 3 HELIX 5 AA5 ALA A 265 HIS A 270 1 6 HELIX 6 AA6 ARG A 276 GLY A 293 1 18 HELIX 7 AA7 ASN A 301 LYS A 312 1 12 HELIX 8 AA8 THR A 321 LEU A 332 1 12 HELIX 9 AA9 ASP A 345 HIS A 352 1 8 HELIX 10 AB1 VAL A 353 SER A 356 5 4 HELIX 11 AB2 ASN A 359 ASN A 365 1 7 SHEET 1 AA1 5 PHE A 98 GLY A 105 0 SHEET 2 AA1 5 LYS A 111 HIS A 117 -1 O LEU A 114 N LYS A 102 SHEET 3 AA1 5 PHE A 123 VAL A 128 -1 O TYR A 124 N ALA A 115 SHEET 4 AA1 5 LEU A 172 ASP A 177 -1 O LEU A 176 N ALA A 125 SHEET 5 AA1 5 LEU A 162 GLN A 167 -1 N HIS A 163 O VAL A 175 SHEET 1 AA2 2 ILE A 228 LEU A 230 0 SHEET 2 AA2 2 ILE A 236 LEU A 238 -1 O VAL A 237 N LEU A 229 CRYST1 92.445 92.445 172.033 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010817 0.006245 0.000000 0.00000 SCALE2 0.000000 0.012491 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005813 0.00000